tradmap

QTTB Q32 Bio Inc.

$12.78 -5.96%

Updated

Healthcare · Pharmaceutical Preparations

Q32 Bio Inc. (QTTB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $380 million. Shares last traded at $12.78, 45.4% below their 52-week high. Over the past year the stock is up 649.6%. QTTB trades at a price-to-earnings ratio of 11.26, below the Pharmaceutical Preparations median of 17.31. Net profit margin is 62.9%, above the peer median of -8.9%.

Market Cap
$380M
Shares Out
29.8M
EPS (TTM)
$-5.47
P/E Ratio
11.26
P/S Ratio
7.08
P/B Ratio
3.59
Dividend / Share
Dividend Yield
52-Week High
$23.41
52-Week Low
$1.62
Volume
26,788
Avg Vol (3m)
38,108.857

Performance

1W
-20.82%
1M
-22.50%
3M
-9.04%
6M
+181.50%
YTD
+272.59%
1Y
+649.56%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
31.76
SMA (50)
$15.08
SMA (200)
$7.99
Price vs SMA50
-15.24%
Price vs SMA200
+59.97%
ATR (14)
$0.96

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$54M
Net Income
$34M
Gross Margin
Operating Margin
39.9%
Net Margin
62.9%
Return on Equity
31.9%
Return on Assets
29.2%
Current Ratio
20.30
Debt / Equity
0.09
Revenue Growth (YoY)

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-0.96 2026-08-05
Q1 2026 $-0.54 2026-05-05
FY 2025 $2.42 2026-03-10
Q3 2025 $-2.29 2025-11-13
Q2 2026 $-1.68 2026-08-05
Q1 2026 $-0.90 2026-05-05

Full earnings history →

Pharmaceutical Preparations peers

QTTB vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated

P/E vs peers
11.26 / 17.31 med
-35% discount
P/S vs peers
7.08 / 11.11 med
-36% discount
Net margin vs peers
62.9% / -8.9% med
above median
1–14 of 14
LLYLilly (Eli)$1.09T40.8613.7033.5%-0.02%
JNJJohnson & Johnson$670.6B31.886.8521.5%+1.04%
ONCBeone Medicines Ltd.$535.9B817.2587.4310.7%+0.23%
ABBVAbbVie$459.8B72.877.149.8%-0.57%
MRKMerck$375.8B118.445.654.8%+0.44%
ABTAbbott Laboratories$189.5B30.204.2013.9%-1.50%
PFEPfizer$164.2B37.912.586.8%-0.76%
VRTXVertex Pharmaceuticals$141.5B32.1111.2435.0%+0.24%
BMYBristol Myers Squibb$139.1B14.982.8318.9%+0.62%
REGNRegeneron Pharmaceuticals$87.2B20.155.6127.9%-1.02%
TEVATeva Pharmaceutical Industries Ltd$42.6B60.412.464.1%-2.32%
ALNYAlnylam Pharmaceuticals$35.4B43.779.5221.8%-1.10%
ZTSZoetis$31.5B12.053.3127.5%+0.16%
RPRXRoyalty Pharma Plc$28.2B34.5611.1132.1%+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.